Donald J. Santel - 30 Jul 2021 Form 3 Insider Report for Oyster Point Pharma, Inc.

Role
Director
Signature
/s/ Brandon Fenn, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
3
Filing time
03 Aug 2021, 20:14:59 UTC
Next filing
13 Aug 2021

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned